PLAY PODCASTS
Helping democratize access and use of mRNA technology
Season 2 · Episode 9

Helping democratize access and use of mRNA technology

The use of mRNA as a vaccine platform has been mostly derisked and its speed to move from antigen discovery to drug product is impressive. However, high-purity mRNA can still be a challenge to make. Dr. Christian Cobaugh, CEO of Vernal Biosciences, is on a mission to make high-purity mRNA available to more researchers and drug developers to help realize even more potential from mRNA medicines.

Absolute Gene-ius · Christian Cobaugh, Jordan Ruggieri, Christina Bouwens

September 4, 202432m 57s

Show Notes

The potential of mRNA medicines was postulated for years, but it took the COVID pandemic and emergency use authorizations for that potential to be demonstrated. By now, most of us have received at least one mRNA based vaccine and the platform has been mostly derisked. However, if you’re not one of the major players in this space, generating high-purity mRNA, let alone a GMP-grade mRNA-based drug product, can still be quite challenging. 

Dr. Chrisitan Cobaugh, CEO of Vernal Biosciences in Vermont, has been working in the mRNA field for more than a decade and is passionate about the potential of mRNA medicines. He’s also been in the field long enough to know firsthand the challenges of high-purity mRNA and lipid nanoparticle supply. Join us as Christian walks us through his story, the start of Vernal Biosciences, and their progress toward their mission of democratizing access to mRNA technology. Our conversation touches on the molecular biology of making mRNA, and the use of digital PCR and other methods in monitoring development and release of mRNA drug products, and the potential applications of mRNA as a platform (some of which you might not have guessed).

Whether you’re new to the technology, or have chosen mRNA as a focus area, you’re sure to find this conversation engaging and intriguing, and our guest insightful. 

Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the Applied Biosystems QuantStudio Absolute Q Digital PCR System. 

Visit the Absolute Gene-ius page to learn more about the guests, the hosts, and the science we explore. Discover the Applied Biosystems QuantStudio Digital and Real-Time PCR Systems powering real-world research across neuroscience, oncology, agriculture, and more.

Topics

lipid nanoparticlehigh-puritycell bankdrug substanceteam culturecdmomultiplexingin vivo gene editingphquantifygateway cloningantibody engineeringmrnapersonalized cancer vaccinevirusesclinical trialsrna structural biologyvalidationplasmid dnaendosomee. coliclone expansionin depth qc testingcapillary electrophoresisgolden gate cloningdrug discoverymolecular biologygibson assemblydraft guidancetemplateusporthogonal methodsrelease assaygmpactive productworkflowsabsorbanceceorelease packagein vitro transcriptionmanufacturingphage displayrna synthesiscdnanisthplcpegylated lipidvermontgene synthesislabilereference standardscytoplasmsingle molecule resolutionmentorqualitycuriositydrug productfdaleadershipclonesequencingpuritydigital pcrcell typevaccine platformsupply chainmolecular methodscholesterolceidentityqpcr